SBL Testing Technologies

Partners with INOV Systems to Deliver COVID-19 Rapid Antibody Tests to Brazil

SBL Testing Technologies Partners with INOV Systems to Deliver COVID-19 Rapid Antibody Tests to Brazil

Recognized provider of workplace testing solutions expands global footprint to provide COVID-19 IgM/IgG Antibody Rapid Tests

Calgary, AB – June 23, 2020 – SBL Testing Technologies (SBL), a company that provides on-site rapid testing technologies and comprehensive support for workplaces to manage risk, announced it has partnered with INOV Systems (INOV), a leading testing distributor in Brazil, to provide COVID-19 IgM/IgG Antibody Rapid Tests to companies restarting business operations.

Through this strategic partnership, Brazilian companies not only have access to antibody tests to help ensure a safe and healthy workplace, but they also benefit from SBL’s leading team of experts, training resources and customer support.

“It’s absolutely critical during these times that companies know who their testing suppliers are and select a partner that is proven to deliver quality, accurate and reliable safety products and solutions – now INOV customers can rest assured they are receiving just that thanks to our partnership,” said Rich Robillard, managing partner, SBL Testing Technologies. “We look forward to not only providing testing kits through INOV, but also supporting the team and their clients with training and a support portal as companies navigate the complex issue of return-to-work protocols.”

“The impact of COVID-19 in Brazil has been significant and continues to be so,” said Diego Nascimento, diretor, INOV. “As part of return-to-work protocols, the tests provided by SBL will deliver peace of mind to employers, employees and consumers. At INOV, we are excited to help increase SBL’s reach in South America and this partnership will allow us to drive business impact for our clients.”

SBL leveraged its relationships with leading high-quality manufacturers to begin providing the COVID-19 antibody test. The COVID-19 IgM/IgG Antibody Rapid Test is a simple point-of-care lateral flow immunoassay detecting IgM and IgG antibodies simultaneously against the COVID-19 virus in human blood within 15 minutes. The test is designed to detect patients at different infection stages. It does not detect the COVID-19 virus itself, but the antibodies produced to fight the virus. This is critical for return-to-work applications. The testing protocol is meant not as a one-time use, but for ongoing workplace testing to manage employees’ health and the safety of on-going operations.

As part of SBL’s comprehensive support services, INOV clients benefit from online competency training for organizations’ health professionals in administration of the test. SBL’s proprietary mobile result reporting app allows clients to manage results from anywhere, in real-time, and build out custom reporting to meet company and local regulatory requirements.

About SBL Testing Technologies

With headquarters in Calgary, Alberta and Austin, Texas, SBL Testing Technologies is a provider of on-site rapid testing technologies and comprehensive support for workplaces to manage risk. SBL has partnerships with leading manufacturers worldwide to offer its clients the highest quality in workplace testing available, along with training and customized support services. The company has clients across the energy, mining, manufacturing, agriculture and transportation industries. For more information, visit www.sbltt.com.

About INOV Systems

Headquartered in Rio de Janeiro, Barra da Tijuca, INOV is always looking for technological innovations that facilitate and increase the control of its customers, offering cutting-edge technology to its customers in the segments of Information Technology, Health and Cybersecurity. For more information, visit www.inovsystems.com.br.

2020-06-25T12:36:35+00:00June 23rd, 2020|Press Release|